| Paciucci, P A; Ryder, J S; Mandell, J P et al. (2000) Interleukin-2 plus chemotherapy for patients with metastatic melanoma. Melanoma Res 10:291-5 |
| Puolakkainen, P; Twardzik, D; Ranchalis, J et al. (1995) Increase of plasma transforming growth factor beta (TGF beta) during immunotherapy with IL-2. Cancer Invest 13:583-9 |
| Silverman, L R; Deligdisch, L; Mandeli, J et al. (1994) Chemotherapy for angiosarcoma of the breast: case report of 30-year survival and analysis of the literature. Cancer Invest 12:145-55 |
| Bhardwaj, S; Holland, J F; Norton, L (1993) An intensive sequenced adjuvant chemotherapy regimen for breast cancer. Cancer Invest 11:6-9 |
| Paciucci, P A; Bekesi, J G; Ryder, J S et al. (1991) Immunotherapy with IL2 by constant infusion and weekly doxorubicin. Am J Clin Oncol 14:341-8 |
| Head, J F; Chahinian, A P; Greengard, O (1991) Enzymic composition and growth rate of human pleural mesothelioma transplants in nude mice. Cancer Biochem Biophys 12:127-36 |
| Crown, J; Lipzstein, R; Cohen, S et al. (1991) Chemotherapy of metastatic Merkel cell cancer. Cancer Invest 9:129-32 |
| Oleksowicz, L; Paciucci, P A; Zuckerman, D et al. (1991) Alterations of platelet function induced by interleukin-2. J Immunother (1991) 10:363-70 |
| Bruckner, H W; Cohen, C; Mandeli, J et al. (1991) Hexamethylmelamine for the treatment of ovarian cancer--the Mount Sinai experience. Cancer Treat Rev 18 Suppl A:57-65 |
| Crown, J P; Chahinian, A P; Jaffrey, I S et al. (1990) Predictors of 5-year survival and curability in small cell lung cancer. Cancer 66:382-6 |
Showing the most recent 10 out of 55 publications
